Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportGeneral Clinical Specialties Track

Is cholecystokinin administration during hepatobiliary imaging a physiologic test?

Isis Gayed, Lydia Dawood, Bella Desai, Usha Joseph and Andrew Dupont
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 1197;
Isis Gayed
1Department of Diagnostic and Interventional Imaging University of Texas-Health Science Center Houston TX United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lydia Dawood
1Department of Diagnostic and Interventional Imaging University of Texas-Health Science Center Houston TX United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bella Desai
1Department of Diagnostic and Interventional Imaging University of Texas-Health Science Center Houston TX United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Usha Joseph
1Department of Diagnostic and Interventional Imaging University of Texas-Health Science Center Houston TX United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew Dupont
2Department of Internal Medicine-Gastroenterology University of Texas-Health Science Center Houston TX United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1197

Objectives: Hepatobiliary scintigraphy with cholecystokinin (CCK) is a well-established test for chronic cholecystitis and gallbladder motility disorders. Many studies have compared the effects of fatty meal versus CCK administration on gallbladder contractility in different patient populations and have concluded that they are comparable. The aim of this study is to evaluate the effect of CCK and half and half milk consecutively administered in the same patient on gallbladder contractility.

Methods: A total of 147 patients underwent a standard hepatobiliary imaging for one hour after administration of 5.0 mCi of Tc-99m Mebrofenin intravenously. If the gallbladder was visualized, the patients were injected slowly with 0.02 ug/kg of CCK over 3 minutes and additional 30 minutes of dynamic imaging was obtained. Patients with gallbladder ejection fraction (GBEF) of less than 35% after CCK stimulation were prospectively included in this study. After consenting to participate in the study, the patient was administered 8 oz of half and half milk orally. This was followed by 15 minutes wait and subsequent additional 30 minutes of dynamic imaging. The GBEF was recalculated after milk administration. The GBEF after CCK was compared with GBEF after milk ingestion. The number of patients with a change of their GBEF from below 35% (abnormal) to above 35% (normal) was recorded.

Results: Out of 147 patients, 23 patients (17 females, 6 males) had abnormal GBEF and were included in this study with an average age of 42.6y. The average GBEF after CCK administration was 13 + 0.07% (range 0 - 26%). The recalculated average GBEF after milk administration was 27 + 0.20% (range 2 - 78%). The average increase in GBEF with the administration of milk after CCK was 14 + 0.23% (range 0 -78%). The GBEF changed from abnormal (GBEF < 35%) to normal (GBEF >35%) in six patients (26%) out of the 23 patients. The remaining 17 patients had an increase in their GBEF at an average of 17 + 0.08% but remained abnormal. Only one patient had pain after CCK administration and was one of those who changed their GBEF from abnormal to normal after adding milk. Another patient had abdominal pain after milk ingestion and her GBEF remained abnormal with both CCK alone and CCK followed by milk.

Conclusion: CCK administration alone over 3 minutes during hepatobiliary scintigraphy is insufficient and non-physiologic for the evaluation of gallbladder contractility. Research Support:

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 58, Issue supplement 1
May 1, 2017
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Is cholecystokinin administration during hepatobiliary imaging a physiologic test?
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Is cholecystokinin administration during hepatobiliary imaging a physiologic test?
Isis Gayed, Lydia Dawood, Bella Desai, Usha Joseph, Andrew Dupont
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 1197;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Is cholecystokinin administration during hepatobiliary imaging a physiologic test?
Isis Gayed, Lydia Dawood, Bella Desai, Usha Joseph, Andrew Dupont
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 1197;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

General Clinical Specialties Track

  • Quantitative Evaluation of Parathyroid Adenoma and Hyperplasia in Reference to Thyroid using Tc-99m MIBI SPECT/CT
  • A primitive study for clinical application of 18F-AlF-NOTA-octreotide PET/CT in combination with 18F-FDG PET/CT for imaging neuroendocrine neoplasms
  • Role of 18F-FDG PET/CT in detection of disease burden and response assessment in patients with myeloid sarcoma
Show more General Clinical Specialties Track

Gastroenterology Posters

  • Usefulness of 18FDG-PET/CT in distinguishing HNF1A-mutated from inflammatory types of hepatocellular adenomas.
  • HEPATOBILIARY SCINTIGRAPHY DIAGNOSIS AND QUALITATIVE CATEGORIZATION OF BILE LEAKS CORRELATED WITH INTERVENTIONS AND OUTCOMES
  • Whether Quantitative Stimulation Test with Dynamic Salivary Gland Scintigraphy Could be Re-included in New Sjogren's Syndrome Classification Criteria
Show more Gastroenterology Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire